The federal government has declared the opioid epidemic a public health emergency that's claimed thousands of lives. Narcan is the only approved nasal spray version of naxolone, costing $150 for two doses. While public health programs can negotiate lower prices, access and affordability remains an issue.
Emergent's Doug White says the company plans to invest in addiction and overdose drugs and work with federal officials to ensure grants to offset costs.
This article has been corrected to fix the spelling of Doug White's first name.
Information from: The Baltimore Sun, http://www.baltimoresun.com